Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.